Literature DB >> 10322136

RNA polymerase II as a control panel for multiple coactivator complexes.

M Hampsey1, D Reinberg.   

Abstract

1999 marks the 30th anniversary of the reported discovery of sigma factor and the bacterial RNA polymerase holoenzyme. In 1994, an RNA polymerase II complex was discovered in yeast - mammalian complexes were subsequently identified. Recent developments regarding the composition and function of RNA polymerase II complexes suggest, however, that the concept of the holoenzyme, as defined in bacteria, might not be relevant to eukaryotes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10322136     DOI: 10.1016/S0959-437X(99)80020-3

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  49 in total

1.  The Spt components of SAGA facilitate TBP binding to a promoter at a post-activator-binding step in vivo.

Authors:  A M Dudley; C Rougeulle; F Winston
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

2.  Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD.

Authors:  D C Schultz; J R Friedman; F J Rauscher
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

3.  Drosophila homologs of transcriptional mediator complex subunits are required for adult cell and segment identity specification.

Authors:  M Boube; C Faucher; L Joulia; D L Cribbs; H M Bourbon
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

Review 4.  Role of histone acetylation in the assembly and modulation of chromatin structures.

Authors:  A T Annunziato; J C Hansen
Journal:  Gene Expr       Date:  2000

Review 5.  Phosphorylation in transcription: the CTD and more.

Authors:  T Riedl; J M Egly
Journal:  Gene Expr       Date:  2000

6.  Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II.

Authors:  S M Carty; A C Goldstrohm; C Suñé; M A Garcia-Blanco; A L Greenleaf
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Genetic analysis of the role of Pol II holoenzyme components in repression by the Cyc8-Tup1 corepressor in yeast.

Authors:  M Lee; S Chatterjee; K Struhl
Journal:  Genetics       Date:  2000-08       Impact factor: 4.562

8.  RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells.

Authors:  H L Jenkins; C A Spencer
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

10.  Transcriptional repressor of vasoactive intestinal peptide receptor mediates repression through interactions with TFIIB and TFIIEbeta.

Authors:  L Pei
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.